ChiCTR2600124556 版本V1.0 版本创建时间2026/05/13 17:43:24 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600124556 

最近更新日期:

Date of Last Refreshed on:

2026-05-13 17:43:18 

注册时间:

Date of Registration:

2026-05-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

非营养性甜味剂、运动、肠道菌群与肥胖成年人代谢健康之间的关联

Public title:

Association Between Non-Nutritive Sweeteners, Exercise, Gut Microbiota, and Metabolic Health in Adults with Obesity

注册题目简写:

English Acronym:

研究课题的正式科学名称:

非营养性甜味剂、运动、肠道菌群与肥胖成年人代谢健康之间的关联

Scientific title:

Association Between Non-Nutritive Sweeteners, Exercise, Gut Microbiota, and Metabolic Health in Adults with Obesity

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郑晨 

研究负责人:

郑晨 

Applicant:

Zheng Chen 

Study leader:

Zheng Chen 

申请注册联系人电话:

Applicant telephone:

+852 2948 7844

研究负责人电话:

Study leader's
telephone:

+852 2948 7844

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

czheng@eduhk.hk

研究负责人电子邮件:

Study leader's E-mail:

czheng@eduhk.hk

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国香港特别行政区新界大埔露屏路10号

研究负责人通讯地址:

中国香港特别行政区新界大埔露屏路10号

Applicant address:

10 Lo Ping Road, Tai Po, New Territories, Hong Kong, China

Study leader's address:

10 Lo Ping Road, Tai Po, New Territories, Hong Kong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

香港教育大学

Applicant's institution:

The Education University of Hong Kong

研究负责人所在单位:

香港教育大学

Affiliation of the Leader:

The Education University of Hong Kong

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

A2024-2025-0699-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

香港教育大学 人类实验对象操守委员会

Name of the ethic committee:

Human Research Ethics Committee (HREC), The Education University of Hong Kong

伦理委员会批准日期:

Date of approved by ethic committee:

2026-04-10 00:00:00

伦理委员会联系人:

Ben Ho

Contact Name of the ethic committee:

Ben Ho

伦理委员会联系地址:

中国香港特别行政区新界大埔露屏路10号

Contact Address of the ethic committee:

10 Lo Ping Road, Tai Po, New Territories, Hong Kong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+852 2948 8120

伦理委员会联系人邮箱:

Contact email of the ethic committee:

wpho@eduhk.hk

研究实施负责(组长)单位:

香港教育大学

Primary sponsor:

The Education University of Hong Kong

研究实施负责(组长)单位地址:

中国香港特别行政区新界大埔露屏路10号

Primary sponsor's address:

10 Lo Ping Road, Tai Po, New Territories, Hong Kong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

香港

市(区县):

Country:

China

Province:

Hong Kong

City:

单位(医院):

香港教育大学

具体地址:

中国香港特别行政区新界大埔露屏路10号

Institution
hospital:

The Education University of Hong Kong

Address:

10 Lo Ping Road, Tai Po, New Territories, Hong Kong, China

经费或物资来源:

自筹

Source(s) of funding:

Self-funded

研究疾病:

肥胖  

Target disease:

Obesity

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

1. 观察非营养性甜味剂(NNS)摄入量、运动和代谢生物标志物之间的关系。 2. 确定肥胖成年人中非营养性甜味剂(NNS)摄入量、运动和肠道菌群之间的关系。  

Objectives of Study:

1. To observe the relationship between non-nutritive sweetener (NNS) consumption, exercise, and metabolic biomarkers. 2. To determine the relationship between NNS consumption, exercise, and gut microbiota in adults with obesity.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄在18至55岁之间的中国成年人; 2. 肥胖:根据亚洲标准,BMI>=25.0 kg/m^2; 3. 无饮酒或吸烟史; 4. 体重在过去3个月内保持稳定。

Inclusion criteria

1. Chinese adults aged between 18 and 55 years; 2. Obesity: based on the Asia cut-off point, BMI >= 25.0 kg/m^2; 3. No current or chronic use of alcohol or tobacco; 4. Body weight has been stable for the past 3 months.

排除标准:

1. 已知有心血管或代谢相关疾病史; 2. 目前正在参与其他试验; 3. 肠易激综合征或对多元醇(糖醇)不耐受; 4. 影响运动能力的疾病(关节炎)或损伤。

Exclusion criteria:

1. known history of cardiovascular or metabolic-related disease; 2. current participation in other trials; 3. irritable bowel syndrome or intolerance to polyols (sugar alcohols); 4. diseases (arthritis) or injuries that affect the ability to exercise.

研究实施时间:

Study execute time:

From 2026-05-15 00:00:00 To 2026-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-15 00:00:00 To 2026-07-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

150

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

香港 

市(区县):

 

Country:

China

Province:

Hong Kong

City:

单位(医院):

香港教育大学 

单位级别:

大学 

Institution
hospital:

The Education University of Hong Kong

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

代谢相关生物标志物

指标类型:

主要指标

Outcome:

Metabolic-related biomarkers

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

人体测量学指标

指标类型:

次要指标

Outcome:

Anthropometric measurements

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肠道菌群

指标类型:

次要指标

Outcome:

Gut microbiota

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

客观测量的身体活动

指标类型:

次要指标

Outcome:

Objectively measured physical activity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

饮食相关的结果

指标类型:

次要指标

Outcome:

Dietary-related outcomes

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

粪便

组织:

Sample Name:

Stool

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 55 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

所有数据已在电脑的Excel软件中整理,并存放在实验室内一台密码保护的电脑上。只有项目负责人可以访问这些数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

All data have been organized in Excel on a password-protected computer in the laboratory. Only the project leader has access to this information.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-05-13 17:43:18